Turner Investments’s Impax Laboratories, Inc. IPXL Stock Holding History

Turner Investments’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,300	Closed	-$612K	–	288
2015 Q4	$612K	Buy	+14,300	New	+$571K	0.13%	181
2014 Q3	–	Sell	-285,970	Closed	-$8.58M	–	612
2014 Q2	$8.58M	Sell	285,970 -136,250	-32%	-$3.68M	0.38%	69
2014 Q1	$11.2M	Sell	422,220 -131,660	-24%	-$3.29M	0.3%	111
2013 Q4	$13.9M	Buy	553,880 +413,260	+294%	+$9.22M	0.25%	139
2013 Q3	$2.88M	Sell	140,620 -8,420	-6%	-$174K	0.05%	344
2013 Q2	$2.97M	Buy	+149,040	New	+$2.65M	0.04%	408

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Turner Investments's IPXL Position: Q1 2016 in Review

Turner Investments sold out of Impax Laboratories, Inc. (IPXL) in Q1 2016, closing a stake of 14,300 shares — an estimated $612K sold.

Turner Investments first reported a position in IPXL in Q2 2013 and held it in 6 quarters. The position peaked at $13.9M in Q4 2013. 194 funds tracked by Wall St. Rank hold IPXL as of Q1 2016.

Turner Investments reported no remaining Impax Laboratories, Inc. position as of Q1 2016 after selling out during the quarter.
Turner Investments sold 14,300 Impax Laboratories, Inc. shares in Q1 2016, an estimated $612K.
Turner Investments first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 6 quarters.
Turner Investments's Impax Laboratories, Inc. position peaked at $13.9M in Q4 2013.
194 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2016.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.